Pacira | PCRX - Attività Correnti





Attività Correnti Cambiamento Data
Assertio Holdings USD 263.57M 53.36M 2025-09
Astellas Pharma JPY 1.44T 72.43B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Coherus Biosciences USD 206.71M 254.25M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
J&J USD 55.62B 1.01B 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Novo Nordisk DKK 172.45B 9.43B 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Xeris Pharmaceuticals USD 224.02M 38.44M 2025-09
Xoma USD 110.71M 5.78M 2025-09
Zoetis USD 6.77B 185M 2025-12